rdf:type |
|
lifeskim:mentions |
umls-concept:C0008809,
umls-concept:C0017262,
umls-concept:C0021757,
umls-concept:C0079460,
umls-concept:C0085278,
umls-concept:C0185117,
umls-concept:C0332281,
umls-concept:C0702240,
umls-concept:C1517004,
umls-concept:C1963758,
umls-concept:C2911684
|
pubmed:issue |
2
|
pubmed:dateCreated |
1998-3-19
|
pubmed:abstractText |
To evaluate the immunomodulatory potential of ciprofloxacin in mice with experimental antiphospholipid syndrome (APS).
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0004-3591
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
41
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
224-32
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:9485080-Adjuvants, Immunologic,
pubmed-meshheading:9485080-Animals,
pubmed-meshheading:9485080-Anti-Infective Agents,
pubmed-meshheading:9485080-Antibody Formation,
pubmed-meshheading:9485080-Antiphospholipid Syndrome,
pubmed-meshheading:9485080-Bone Marrow,
pubmed-meshheading:9485080-Ceftazidime,
pubmed-meshheading:9485080-Cell Count,
pubmed-meshheading:9485080-Ciprofloxacin,
pubmed-meshheading:9485080-Colony-Forming Units Assay,
pubmed-meshheading:9485080-Female,
pubmed-meshheading:9485080-Granulocyte-Macrophage Colony-Stimulating Factor,
pubmed-meshheading:9485080-Interleukin-3,
pubmed-meshheading:9485080-Megakaryocytes,
pubmed-meshheading:9485080-Mice,
pubmed-meshheading:9485080-Mice, Inbred BALB C,
pubmed-meshheading:9485080-Pregnancy,
pubmed-meshheading:9485080-Spleen
|
pubmed:year |
1998
|
pubmed:articleTitle |
Ciprofloxacin immunomodulation of experimental antiphospholipid syndrome associated with elevation of interleukin-3 and granulocyte-macrophage colony-stimulating factor expression.
|
pubmed:affiliation |
Sheba Medical Center, Tel-Hashomer, Israel.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|